In recent years, genes such as apolipoprotein C3 (APOC3), leptin receptor (LEPR) and peroxisome proliferator‐activated receptors (PPAR) have been reported to be associated with NAFLD and CAD [4]. This evidence concerns the gene APOC3 and metabolic dysfunction-associated steatotic liver disease.